<<<<<Continuing the creative uses of DepoFoam technology possibilities
<<<<<HIV protease inhibitor
...you have probably seen this--but for those who have not--studying anti-retrovirals and interferon
Publications
Please send the following publications:
(Select all appropriate boxes.)
Product Literature:
DepoAmikacin product literature
DepoCyt product literature
DepoMorphine product literature
Investor Relations Literature:
DepoTech Investor Relations Package, including 1996 Annual Report
DepoTech 1996 Annual Report
Company Publications:
24. Topology of Multivesicular Liposomes, A Model Biliquid Foam,
Langmuir Vol. 12 No. 20: 4704-4708, October 12,1996.
M.S. Spector, J.A. Zasadzinski, M.B. Sankaram.
23. An Electron Microscopy Study of the Structure of Multivesicular Liposomes,
BioMedical Research Foundation, Tokyo,
Progress in Drug Delivery System Vol. 5, 1996.
M.S. Spector, J.A. Zasadzinski, M.B. Sankaram.
22. Sustained-release Morphine for Epidural Analgesia in Rats,
Anesthesiology 85: 331-338, August 1996. Tahehee Kim, Sharad
Murdande, Andras Gruber, Sinil Kim.
21. Soft Tissue Infection Prophylaxis with Gentamicin Encapsulated in
Multivesicular Liposomes: Results From a Prospective, Randomized Trial,
Critical Care Medicine 23: 84-91, January 1995. Lelia S. Grayson, John F.
Hansbrough, Ramon Zapata-Sirvent, Ansgar J. Roehborn, Taehee Kim, Sinil Kim.
20. DepoFoam-Mediated Drug Delivery into Cerebrospinal Fluid,
Methods in Neurosciences 21: 118-131, 1994. Sinil Kim.
19. An Extended-Release Formulation of Methotrexate for Subcutaneous Administration,
Cancer Chemother Pharmacol 33: 303-306, 1994. Andrea Bonetti, Etienne Chatelut, Sinil Kim.
18. Sustained-Release Methotrexate for Intracavitary Chemotherapy,
Journal of Pharmaceutical Sciences 83: 429-432, March 1994. Etienne Chatelut, Peter Suh,
Sinil Kim.
17. Pharmacokinetics of an Extended-Release Human Interferon Alpha-2b Formulation,
Cancer Chemother Pharmacol 33: 258-261, 1993. Andrea Bonetti, Sinil Kim.
16. Liposomes as Carriers of Cancer Chemotherapy: Current Status and Future
Prospects,
Drugs 46 (4): 618-638, 1993. Sinil Kim.
15. Extended-Release Formulation of Morphine for Subcutaneous Administration,
Cancer Chemother Pharmacol 33: 187-190, 1993. Taehee Kim, Joon Kim, Sinil Kim.
14. Extended CSF Cytarabine Exposure Following Intrathecal Administration of
DTC101,
Journal of Clinical Oncology 11: 2186-2193, November 1993. Sinil Kim, Etienne Chatelut,
Joseph C. Kim, Stephen B. Howell, Charles Cates, Patricia A. Kormanik, Marc C. Chamberlain.
13. Prolongation of Drug Exposure in Cerebrospinal Fluid by Encapsulation into
DepoFoam,
Cancer Research 53: 1596-1598, April 1993. Sinil Kim, Shirin Khatibi, Stephen B. Howell,
Cindy McCully, Frank M. Balis, David G. Poplack.
12. Quantitative Cerebrospinal Fluid Cytology in Patients Receiving Intracavitary
Chemotherapy,
Annals of Neurology, 34: 108-112, July 1993. Valentina Russack, M.D.; Sinil Kim, M.D.;
Marc C. Chamberlain, M.D.
11. A Slow-Release Methotrexate Formulation for Intrathecal Chemotherapy,
Cancer Chemother Pharmacol 32: 179-182, 1993. Etienne Chatelut, Taehee Kim, Sinil Kim.
10. Treatment of Leptomeningeal Metastasis with Intraventricular Administration of
Depot Cytarabine (DTC101),
Arch Neurol 50: 261-264, March 1993. Marc C. Chamberlain, M.D.; Shirin Khatibi, D.V.M.;
Joseph C. Kim; Stephen B. Howell, M.D.; Etienne Chatelut, Ph.D.; Sinil Kim, M.D.
9.ÿÿ Pharmacokinetics of DepoFoam Gentamicin Delivery System and Effect on Soft
Tissue Infection,
Journal of Surgical Research 54: 559-564, January1993. Leila S. Grayson, M.D.;
John F. Hansbrough, M.D.; Ramon L. Zapata-Sirvent, M.D.; Taehee Kim, Sinil Kim, M.D.
8.ÿÿ Multivesicular Liposomes Containing Bleomycin for Subcutaneous Administration,
Cancer Chemother Pharmacol 28: 105-108, 1991. Romi Roy, Sinil Kim.
7.ÿÿ Direct Cerebrospinal Fluid Delivery of the Antiretroviral Agent Using Multivesicular
Liposomes,
Journal of Infectious Diseases 162: 750-752, September 1990. Sinil Kim, Shelia Scheerer,
Mark A. Geyer, Stephen B. Howell.
6.ÿÿ Intratumoral Chemotherapy with Multivesicular Liposomes Containing Cytosine
Arabinoside,
Reg Cancer Treat 2: 170-173, 1989. Sinil Kim, Shirin Khatibi, Stephen B.
Howell, Sheila Scheerer.
5.ÿÿ Modulation of the Peritoneal Clearance of Liposomal Cytosine Arabinoside by Blank
Liposomes,
Cancer Chemother Pharmacol 19: 307-310, 1987. Sinil Kim, David J. Kim, Stephen B. Howell.
4.ÿÿ Multivesicular Liposomes Containing Cytarabine Entrapped in the Presence of
Hydrochloric Acid for Intracavitary Chemotherapy,
Cancer Research 47: 3935-3937, August 1987. Sinil Kim and Stephen B. Howell.
3.ÿÿ Multivesicular Liposomes Containing 1--D-Arabinofuranosylcytosine for
Slow-Release Intrathecal Therapy,
Cancer Treatment Reports 71: 705-711, July 1987. Sinil Kim, David J. Kim, Mark A. Geyer,
Stephen B. Howell.
2.ÿÿ Multivesicular Liposomes Containing Cytarabine for Slow-Release Sc
Administration,
Cancer Treatment Reports 71: 447-450, May 1987. Sinil Kim, Stephen B. Howell.
1.ÿÿ Preparation of Multilamellar Vesicles of Defined Size-Distribution by
Solvent-Spherule Evaporation,
Biochimica et Biophysica Acta 812: 793-801, 1985. Sinil Kim, Russell E. Jacobs, Stephen
H. White |
